StockData
Retension Pharmaceuticals, Inc. logo

Retension Pharmaceuticals, Inc. (RTSN) stock analysis

RTSNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$12.27+0.02 (+0.16%)

Close on Nov 13, 2026Market cap –P/E –Yield –

Analysis

Not enough annual history yet

Analysis needs at least two fiscal years of reported financials for Retension Pharmaceuticals.

See a number that looks wrong?